Clinical Trial Update: Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating Lorundrostat for uncontrolled and resistant hypertension, focusing on efficacy and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Lorundrostat (lorundrostat)

Snippet

Sponsor: Mineralys Therapeutics Inc. | Conditions: Hypertension | Phase 3 | Status: COMPLETED